# FDA 483 - Fresenius Kabi Oncology Limited - October 10, 2023

Source: https://www.globalkeysolutions.net/records/483/fresenius-kabi-oncology-limited/fe3c67ce-6ae7-4fec-b346-4bb802c84a55

> FDA 483 for Fresenius Kabi Oncology Limited on October 10, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Fresenius Kabi Oncology Limited
- Inspection Date: 2023-10-10
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/fresenius-kabi-oncology-limited/d35ff996-d73a-479a-a447-ad6c3c9c8424)

## Related Officers

- [Thomas J. Cosgrove](https://www.globalkeysolutions.net/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Consumer Safety Officer ](https://www.globalkeysolutions.net/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)

Company: https://www.globalkeysolutions.net/companies/fresenius-kabi-oncology-limited/d092c98c-aa35-490f-97c4-3ed02fe7dac7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c